NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-LM-17-005 from the NIH Guide for Grants and Contracts
Notice NOT-NS-17-027 from the NIH Guide for Grants and Contracts
Notice NOT-OD-17-062 from the NIH Guide for Grants and Contracts
Notice NOT-HS-17-015 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-17-508 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator (PD/PI) of the current Data Coordinating Center (DCC) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study. This DCC has been involved in study design and data and biosample acquisition and management since the inception of the TEDDY Consortium. This FOA provides support for the TEDDY DCC to continue to follow TEDDY children, allowing collaborators to conduct further studies in the measurement and analysis of immune markers using samples from TEDDY subjects.
Notice NOT-OD-17-059 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-004 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-003 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-006 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-005 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-008 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-007 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-010 from the NIH Guide for Grants and Contracts
Notice NOT-NR-17-009 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-18-006 from the NIH Guide for Grants and Contracts. The purpose of this Small Business Technology Transfer (STTR) RFA is to develop a nasal delivery formulation that reliably delivers of a therapeutic (e.g., peptides, antibodies, RNAi, or pharmacotherapeutics), at a physiologically relevant concentration, into the central nervous system (CNS).
Funding Opportunity RFA-DA-18-007 from the NIH Guide for Grants and Contracts. The purpose of this Small Business Technology Transfer (STTR) RFA is to develop a nasal delivery formulation that reliably delivers of a therapeutic (e.g., peptides, antibodies, RNAi, or pharmacotherapeutics), at a physiologically relevant concentration, into the central nervous system (CNS).
Funding Opportunity RFA-AG-18-008 from the NIH Guide for Grants and Contracts. The NIA seeks applications proposing a Coordinating Center (CC) for the Claude D. Pepper Older Americans Independence Centers (OAIC) program. The CC serves a facilitating role for OAIC site interactions as well as a conduit for translating OAIC objectives and findings to both scientific and general audiences. The proposed CC must demonstrate an ability to work cooperatively with all OAIC sites and possess sufficient scientific expertise in geriatrics and related areas to serve the national clearinghouse functions of the OAIC program. The CC should be proposed only by institutions with (1) the ability to coordinate multi-site projects as demonstrated by previous HHS funding for a coordinating center of a multi-site research grant, and (2) demonstrated scientific expertise in clinical aging research.
Funding Opportunity PA-17-262 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research by addressing scientific areas of primary interest to NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB) and the Office of AIDS Research (OAR). This FOA will further explain our interests over the next three years.
Funding Opportunity PAR-17-263 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high risk, high impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2.
Funding Opportunity RFA-NS-17-023 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the development and validation of pathophysiologically based preclinical outcome measures or functional markers that align closely with practical clinical assessments in spinal cord injury (SCI) and/or traumatic brain injury (TBI). Bedside knowledge and experience will be leveraged to create better assessment tools for preclinical studies, and the resulting data will be made available to researchers. The goal is to improve the value of preclinical studies to inform clinical diagnoses and prognoses and therapeutic translation.